Keenova Therapeutics plc 3 SEC Filings

Filed On	Filing
12 Nov 2025	Form 3: Silver Point Capital L.p., 10% owner and 2 others Holds 4,213,724 shares of Common Stock
01 Oct 2025	Form 3: Honczarenko Marek, EVP & Chief Scientific Officer No securities owned
25 Sep 2025	Form 3: Stamoulis Christiana, President and CFO No securities owned
28 Aug 2025	Form 3: Raciti Frank B., Controller & CAO No securities owned
04 Aug 2025	Form 3: Yoskowitz Marc J, Director Holds 787 shares of Ordinary Shares
04 Aug 2025	Form 3: Langlois Sophia D., Director Holds 795 shares of Ordinary Shares
04 Aug 2025	Form 3: Hirsch Scott, Director Holds 455 shares of Ordinary Shares
04 Aug 2025	Form 3: Efron Paul, Director Holds 773 shares of Ordinary Shares
04 Aug 2025	Form 3: Williamson Susan Ann, EVP & Chief Compliance Officer No securities owned
04 Aug 2025	Form 3: Stouch Cheryl Ann, EVP & Chief Info Officer No securities owned
04 Aug 2025	Form 3: Donato Leslie E, Director No securities owned
04 Aug 2025	Form 3: Bradley Mark T., EVP, Chief Integration Officer No securities owned
04 Aug 2025	Form 3: Basso Tracy, EVP & CHRO No securities owned
11 Mar 2024	Form 3: ONeill Hugh Paul, EVP, Qual & Ops, Spec Brands
14 Feb 2024	Form 3: Wheeler Wesley, Director No securities owned
12 Feb 2024	Form 3: Dorton Katina, Director No securities owned
12 Feb 2024	Form 3: Hussain Abbas, Director No securities owned
12 Feb 2024	Form 3: Bisaro Paul, Director No securities owned
13 Dec 2023	Form 3: Goldentree Asset Management Lp, 10% owner and 2 others Holds 1,996,023 shares of Ordinary Shares
22 Nov 2023	Form 3: Zinman Jon, Director No securities owned

Comments